Clinical Trial Update: Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Pancreaze (pancrelipase) in patients with pancreatic adenocarcinoma and exocrine pancreatic insufficiency; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Pancreaze (pancrelipase)

Snippet

Sponsor: Andrew Hendifar, MD | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-07